Centre Hospitalier Intercommunal De Castres Mazamet
- Address
- lock Available on a paid plan
Female Urogenital Diseases and Pregnancy Complications
At Centre Hospitalier Intercommunal De Castres Mazamet, clinical research in obstetric gynecology focuses on female urogenital diseases, especially bacterial vaginosis, vulvovaginal candidiasis, and mixed vaginal infections. These studies are designed to evaluate new treatment options and compare their effectiveness against standard care or placebo in women with acute vaginal infection.
- Testing a new local therapy for acute vaginal infections
- Comparing treatment effectiveness in bacterial vaginosis and vulvovaginal candidiasis
- Assessing symptom improvement in mixed vaginal infections
The research aims to improve care for common gynecological infections by identifying therapies that may offer better relief and clinical outcomes for patients.
Bacterial Infections and Mycoses
This site also contributes to research on bacterial infections and related infectious diseases, including bartonellosis and cat scratch disease. The trials explore whether adding a targeted intervention can improve recovery in patients with suppurative lymphadenitis, helping clarify the value of new approaches in infection management.
- Studying treatment options for cat scratch disease lymphadenitis
- Evaluating outcomes in bartonellosis-related infection
- Exploring ways to strengthen care for suppurative bacterial disease
These studies are focused on improving treatment effectiveness and supporting better recovery in patients with difficult-to-manage infectious conditions.
Digestive System Diseases
Research in digestive system diseases at the Castres site includes studies in colon carcinoma, with a particular interest in guiding adjuvant treatment decisions after surgery. The work is centered on improving long-term outcomes and identifying patients who may benefit most from additional therapy.
- Investigating treatment strategies for colon cancer
- Using biomarkers to help guide post-surgical care
- Evaluating approaches to improve disease-free survival
By focusing on cancer recurrence risk and treatment selection, the research supports more personalized care for people with colorectal cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Intercommunal De Castres Mazamet
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of BGY-1601-VT Vaginal Tablet in Treating Acute Vaginal Infections in Women: A Randomized, Double-Blind, Placebo-Controlled Study | Nexbiome Therapeutics | Phase I/II | Not Recruiting | Oct 2024 | Feb 2026 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azithromycin | 1 | Unknown | 2017-05-31 | 2017-05-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.